For MMP11 rs738792, patients with the “CT + TT” genotype had a higher risk (AHR = 6.562, 95% CI = 1.612−26.704) for cancer death compared with the “CC” wild-type carriers (Table 5). The gene discussed is MMP11; the disease is cancer.